Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology...
products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
Next
(4)
•••
jamesfc
X
View Profile
View Bullboard History
Post by
jamesfc
on Nov 13, 2020 9:50am
thanks
Hey R0nald, your updates from the teleconference are much appreciated (and sound very promising)!
(11)
•••
r0nald
X
View Profile
View Bullboard History
Post by
r0nald
on Nov 13, 2020 9:28am
CM: "we like to buy as much as we can
Looks like they're going to take the share buy backs seriously from now on. They're going to be an active buyer (their words, not mine)
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(11)
•••
r0nald
X
View Profile
View Bullboard History
Post by
r0nald
on Nov 13, 2020 9:27am
Trulance arbitration results before end of january
if not sooner. Also still in talks to come to an agreement.
(11)
•••
r0nald
X
View Profile
View Bullboard History
Post by
r0nald
on Nov 13, 2020 9:25am
Tax Losses
Did I hear that correctly? Will the tax losses of, what was it $100 million (?), be used by end of 2020(!). They are in talks about that? What should that be worth $10-20 million? Amazing!
(3530)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Nov 13, 2020 9:15am
RE:RE:RE:Q3 Results....Cipher earns $1.6 m US in Q3
Note also that book value has increased by $6 million cad in 2020 so far in 2020. With all debt paid down, free cash flows in Q4 will accelerate book value
(3530)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Nov 13, 2020 5:09am
RE:RE:Q3 Results....Cipher earns $1.6 m US in Q3
Other Notes.. 1....The Company received a notice of termination from Bausch Health for alleged breach of contract in respect of its licensing agreement for Trulance. The Company is currently in
...more
(23)
•••
shareswapper
X
View Profile
View Bullboard History
Post by
shareswapper
on Nov 12, 2020 9:09pm
Good News and Bad News
Good news is they paid off the Debt, bad news is the Debts was $25 Million for a bag of assets that have not amounted to anything. Good news is the Net Cash (cash - credit line) is $3.0 Million.
...more
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Nov 12, 2020 8:49pm
RE:Q3 Results....Cipher earns $1.6 m US in Q3
R&D expenditures were almost nil. What's the budget going forward?
(3530)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Nov 12, 2020 8:21pm
Q3 Results....Cipher earns $1.6 m US in Q3
Cipher earns $1.6-million (U.S.) in Q3 2020-11-12 19:36 ET - News Release Mr. Craig Mull reports CIPHER PHARMACEUTICALS REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS
...more
(3530)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Nov 12, 2020 6:39pm
Solid Quarter Earning $1.6 million US = $0.08 cad per share
From Sedar ..
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >